Patents by Inventor Charles Clevenger

Charles Clevenger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EDGE EXCLUSION CONTROL
    Publication number: 20210375591
    Abstract: Provided herein are methods and apparatuses for controlling uniformity of processing at an edge region of a semiconductor wafer. In some embodiments, the methods include exposing an edge region to treatment gases such as etch gases and/or inhibition gases. Also provided herein are exclusion ring assemblies including multiple rings that may be implemented to provide control of the processing environment at the edge of the wafer.
    Type: Application
    Filed: April 19, 2019
    Publication date: December 2, 2021
    Inventors: Anand Chandrashekar, Eric H. Lenz, Leonard Wai Fung Kho, Jeffrey Charles Clevenger, In Su Ha
  • Methods and compositions for modulating somatolactogenic functions
    Patent number: 7902341
    Abstract: Compositions containing cyclophilin B, mutants of cyclophilin B or inhibitors of cyclophilin B and methods of using these compositions to modulate somatolactogenic function are provided.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: March 8, 2011
    Assignee: Trustees of the University of Pennsylvania
    Inventors: Charles Clevenger, Michael A. Rycyzyn
  • Serum Prolactin Binding Protein in Epithelial Carcinoma
    Publication number: 20100273188
    Abstract: The present invention relates to antibodies that have specificity towards prolactin binding protein (PRLBP) that is either bound to a binding partner or unbound to a binding partner, as well as antibodies towards PRLBP regardless of the binding state of PRLBP. The present invention also provides methods of using these PRLBP-specific antibodies, such as method of diagnosing and monitoring the progression of diseases such as epithelial carcinomas, osteoporosis, infertility and cachexia.
    Type: Application
    Filed: February 26, 2010
    Publication date: October 28, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Charles CLEVENGER, William Sweet
  • Serum Prolactin Binding Protein in Epithelial Carcinoma
    Publication number: 20070092920
    Abstract: The present invention relates to antibodies that have specificity towards prolactin binding protein (PRLBP) that is either bound to a binding partner or unbound to a binding partner, as well as antibodies towards PRLBP regardless of the binding state of PRLBP. The present invention also provides methods of using these PRLBP-specific antibodies, such as method of diagnosing and monitoring the progression of diseases such as epithelial carcinomas, osteoporosis, infertility and cachexia.
    Type: Application
    Filed: October 24, 2006
    Publication date: April 26, 2007
    Inventors: Charles Clevenger, William Sweet
  • Methods and compositions for modulating somatolactogenic functions
    Publication number: 20070032423
    Abstract: Compositions containing cyclophilin B, mutants of cyclophilin B or inhibitors of cyclophilin B and methods of using these compositions to modulate somatolactogenic function are provided.
    Type: Application
    Filed: July 17, 2006
    Publication date: February 8, 2007
    Inventors: Charles Clevenger, Michael Rycyzyn
  • Methods and compositions for modulating somatolactogenic functions
    Patent number: 7105306
    Abstract: Compositions containing cyclophilin B, mutants of cyclophilin B or inhibitors of cyclophilin B and methods of using these compositions to modulate somatolactogenic function are provided.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: September 12, 2006
    Assignee: Trustees of the University of Pennsylvania
    Inventors: Charles Clevenger, Michael A. Rycyzyn
  • Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors
    Publication number: 20060094646
    Abstract: Methods are provided for inhibiting growth of prolactin-responsive cancer cells and treating prolactin-responsive malignancies via administration an agent such as cyclosporine A which directly inhibits an enzymatic activity of a cyclophilin.
    Type: Application
    Filed: October 26, 2005
    Publication date: May 4, 2006
    Inventor: Charles Clevenger
  • Composition and method for modulating somatolactogenic function
    Publication number: 20050164309
    Abstract: A human prolactin-binding protein and compositions and methods using this protein are provided.
    Type: Application
    Filed: January 31, 2005
    Publication date: July 28, 2005
    Inventors: Charles Clevenger, J. Kline